MAPK8 and glioblastoma: It was observed that, treatment with inhibitors for both Jnk (SP600125) and Erk (U0126) led to significant inhibition of the migration capacity of U87MG GBM cell line, although the effect was more pronounced when Erk was inhibited as compared to the inhibition of Jnk (Figure 5A and 5B).